NL-OMON32343已完成4 期
Inhibition of platelet activation by clopidogrel in type II diabetes mellitus patients - clopi2008
niversitair Medisch Centrum Utrecht0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •1. healthy controls (matched by age and gender)
- •2. type II DM patients, treated with oral bloodglucose lowering agents (biguanides or sulfonylurea derivates)
排除标准
- •pregnancy; use of anti-epileptic drugs; use of acetylsalicylacid, NSAID, GPIIb-IIa antagonists, heparin or thrombolytica; known diabetic retinopathy; smoking; hypersensitivity to the drug substance or any component of the product; severe liverfunctiondisorder; active pathological bleeding such as peptic ulcer or intracranial hemorrhage; breastfeeding; surgery or dental operation 7 days prior or 7 days after the start of clopidogrel intake; galactose intolerance, lapp lactase deficiency or glucose galactose malabsorbtion
研究者
相似试验
进行中(未招募)
不适用
Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients - Plavix and PrasugrelTo investigate the feasibility, safety and cost of using the platelet assay VerifyNow-P2Y12 to guide optimal P2Y12 platelet inhibition in patients undergoing elective PCI, compared with standard treatment, at a UK tertiary referral cardiology centre.EUCTR2010-018435-18-GBPapworth Hospital NHS Foundation Trust200
Unknown
不适用
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3AThrombosisHypercholesterolemiaNCT00004564National Center for Research Resources (NCRR)
已完成
不适用
High-on Clopidogrel Platelet Reactivity as Assessed by Thromboelastography in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.I21I25I26Chronic ischaemic heart diseaseAcute myocardial infarctionPulmonary embolismDRKS00024509Kardiologie und Angiologie172
进行中(未招募)
1 期
Assessment of platelet inhibitory response to clopidogrel when coadministered with a proton pump inhibitor - Plavix and PPI studyEUCTR2009-011543-40-GBPapworth Hospital72
已完成
不适用
Platelet response to prasugrel and clopidogrel loadinig doses in elective PCI patientsElective PCIJPRN-UMIN000017624Division of Cardiovascular Medicine, Jichi Medical University School of Medicine40
